UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 492

Sortiert nach

Not performing an OGTT results in significant underdiagnosis of (pre)diabetes in a high risk adult Caucasian population

International Journal of Obesity, 2017-11, Vol.41 (11), p.1615-1620

2017

Volltextzugriff (PDF)

Environmental pollutants and type 2 diabetes: a review of mechanisms that can disrupt beta cell function

Diabetologia, 2011-06, Vol.54 (6), p.1273-1290

2011

Volltextzugriff (PDF)

Screening for therapeutic trials and treatment indication in clinical practice: MACK‐3, a new blood test for the diagnosis of fibrotic NASH

Alimentary Pharmacology & Therapeutics (Suppl), 2018-05, Vol.47 (10), p.1387-1396

2018

Volltextzugriff (PDF)

A randomized double-blind placebo-controlled study of the long-term efficacy and safety of topiramate in the treatment of obese subjects

International Journal of Obesity, 2004-11, Vol.28 (11), p.1399-1410

2004

Volltextzugriff (PDF)

LEADER 5: prevalence and cardiometabolic impact of obesity in cardiovascular high-risk patients with type 2 diabetes mellitus: baseline global data from the LEADER trial

Cardiovascular diabetology, 2016-02, Vol.15 (1), p.29, Article 29

2016

Volltextzugriff (PDF)

Obesity, haemostasis and the fibrinolytic system

Obesity reviews, 2002-05, Vol.3 (2), p.85-101

2002

Volltextzugriff (PDF)

Visceral, subcutaneous abdominal adiposity and liver fat content distribution in normal glucose tolerance, impaired fasting glucose and/or impaired glucose tolerance

International Journal of Obesity, 2015-03, Vol.39 (3), p.495-501

2015

Volltextzugriff (PDF)

Assessing the impact of complications on the costs of Type II diabetes

Diabetologia, 2002-07, Vol.45 (7), p.S13-S17

2002

Volltextzugriff (PDF)

Among inflammation and coagulation markers, PAI-1 is a true component of the metabolic syndrome

International Journal of Obesity, 2006-08, Vol.30 (8), p.1308-1314

2006

Volltextzugriff (PDF)

Mutation screen of the SIM1 gene in pediatric patients with early-onset obesity

International Journal of Obesity, 2014-07, Vol.38 (7), p.1000-1004

2014

Volltextzugriff (PDF)

Pivotal Role for the Visceral Fat Compartment in the Release of Persistent Organic Pollutants During Weight Loss

The journal of clinical endocrinology and metabolism, 2015-12, Vol.100 (12), p.4463-4471

2015

Volltextzugriff (PDF)

CA-180: La quantité et la densité du tissu adipeux viscéral, mesurés par tomodensitométrie, sont indépendamment associées au profil de risque cardiométabolique : résultats de l'étude internationale INSPIRE ME IAA

Diabetes & metabolism, 2016-03, Vol.42, p.A84-A84

2016

Volltextzugriff (PDF)

Glycaemic target attainment in people with Type 2 diabetes treated with insulin glargine/lixisenatide fixed‐ratio combination: a post hoc analysis of the LixiLan‐O and LixiLan‐L trials

Diabetic medicine, 2020-02, Vol.37 (2), p.256-266

2020

Volltextzugriff (PDF)

Visceral adiposity and insulin resistance are independent predictors of the presence of non-cirrhotic NAFLD-related portal hypertension

International Journal of Obesity, 2011-02, Vol.35 (2), p.270-278

2011

Volltextzugriff (PDF)

Association of 1-deoxy-sphingolipids with steatosis but not steatohepatitis nor fibrosis in non-alcoholic fatty liver disease

Acta diabetologica, 2021-03, Vol.58 (3), p.319-327

2021

Volltextzugriff (PDF)

Maintained intentional weight loss reduces cardiovascular outcomes: results from the Sibutramine Cardiovascular OUTcomes (SCOUT) trial

Diabetes, obesity & metabolism, 2012-06, Vol.14 (6), p.523-530

2012

Volltextzugriff (PDF)

Relationship between HbA1c levels and risk of cardiovascular adverse outcomes and all-cause mortality in overweight and obese cardiovascular high-risk women and men with type 2 diabetes

Diabetologia, 2012-09, Vol.55 (9), p.2348-2355

2012

Volltextzugriff (PDF)

Human leptin: from an adipocyte hormone to an endocrine mediator

European journal of endocrinology, 2000-09, Vol.143 (3), p.293

2000

Volltextzugriff (PDF)

Visceral adipose tissue and inflammation correlate with elevated liver tests in a cohort of overweight and obese patients

International Journal of Obesity, 2010-05, Vol.34 (5), p.899-907

2010

Volltextzugriff (PDF)

Do E‐cigarettes induce weight changes and increase cardiometabolic risk? A signal for the future

Obesity reviews, 2017-10, Vol.18 (10), p.1136-1146

2017

Volltextzugriff (PDF)

Relationship of body mass index with efficacy of exenatide twice daily added to insulin glargine in patients with type 2 diabetes

Diabetes, obesity & metabolism, 2016-08, Vol.18 (8), p.829-833

2016

Volltextzugriff (PDF)

Sleep-Disordered Breathing and the Metabolic Syndrome in Overweight and Obese Children and Adolescents

The Journal of pediatrics, 2007-06, Vol.150 (6), p.608-612

2007

Volltextzugriff (PDF)

Screening for type 2 diabetes mellitus in overweight and obese subjects made easy by the FINDRISC score

Journal of diabetes and its complications, 2016-08, Vol.30 (6), p.1043-1049

2016

Volltextzugriff (PDF)

Drug-induced obesity and its metabolic consequences: a review with a focus on mechanisms and possible therapeutic options

Journal of endocrinological investigation, 2017-11, Vol.40 (11), p.1165-1174

2017

Volltextzugriff (PDF)

Reference values for sleep-related respiratory variables in asymptomatic European children and adolescents

Pediatric pulmonology, 2007-02, Vol.42 (2), p.159-167

2007

Volltextzugriff (PDF)

1 – 25 von 492

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(444)
Mit Volltextzugriff
(406)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Not performing an OGTT results in significant underdiagnosis of (pre)diabetes in a high risk adult Caucasian population

Environmental pollutants and type 2 diabetes: a review of mechanisms that can disrupt beta cell function

Screening for therapeutic trials and treatment indication in clinical practice: MACK‐3, a new blood test for the diagnosis of fibrotic NASH

A randomized double-blind placebo-controlled study of the long-term efficacy and safety of topiramate in the treatment of obese subjects

LEADER 5: prevalence and cardiometabolic impact of obesity in cardiovascular high-risk patients with type 2 diabetes mellitus: baseline global data from the LEADER trial

Obesity, haemostasis and the fibrinolytic system

Visceral, subcutaneous abdominal adiposity and liver fat content distribution in normal glucose tolerance, impaired fasting glucose and/or impaired glucose tolerance

Assessing the impact of complications on the costs of Type II diabetes

Among inflammation and coagulation markers, PAI-1 is a true component of the metabolic syndrome

Mutation screen of the SIM1 gene in pediatric patients with early-onset obesity

Pivotal Role for the Visceral Fat Compartment in the Release of Persistent Organic Pollutants During Weight Loss

CA-180: La quantité et la densité du tissu adipeux viscéral, mesurés par tomodensitométrie, sont indépendamment associées au profil de risque cardiométabolique : résultats de l'étude internationale INSPIRE ME IAA

Glycaemic target attainment in people with Type 2 diabetes treated with insulin glargine/lixisenatide fixed‐ratio combination: a post hoc analysis of the LixiLan‐O and LixiLan‐L trials

Visceral adiposity and insulin resistance are independent predictors of the presence of non-cirrhotic NAFLD-related portal hypertension

Association of 1-deoxy-sphingolipids with steatosis but not steatohepatitis nor fibrosis in non-alcoholic fatty liver disease

Maintained intentional weight loss reduces cardiovascular outcomes: results from the Sibutramine Cardiovascular OUTcomes (SCOUT) trial

Relationship between HbA1c levels and risk of cardiovascular adverse outcomes and all-cause mortality in overweight and obese cardiovascular high-risk women and men with type 2 diabetes

Human leptin: from an adipocyte hormone to an endocrine mediator

Visceral adipose tissue and inflammation correlate with elevated liver tests in a cohort of overweight and obese patients

Do E‐cigarettes induce weight changes and increase cardiometabolic risk? A signal for the future

Relationship of body mass index with efficacy of exenatide twice daily added to insulin glargine in patients with type 2 diabetes

Sleep-Disordered Breathing and the Metabolic Syndrome in Overweight and Obese Children and Adolescents

Screening for type 2 diabetes mellitus in overweight and obese subjects made easy by the FINDRISC score

Drug-induced obesity and its metabolic consequences: a review with a focus on mechanisms and possible therapeutic options

Reference values for sleep-related respiratory variables in asymptomatic European children and adolescents

Suchergebnisse filtern